# Clinical Trial Evaluation of a Test Serum Post HEV (High Energy Visible) Light Exposure

> **NCT03594721** · NA · COMPLETED · sponsor: **Allergan** · enrollment: 12 (actual)

## Conditions studied

- Blue Light Damage

## Interventions

- **OTHER:** Marvel AM

## Key facts

- **NCT ID:** NCT03594721
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-06
- **Primary completion:** 2018-08-30
- **Final completion:** 2018-08-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03594721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03594721, "Clinical Trial Evaluation of a Test Serum Post HEV (High Energy Visible) Light Exposure". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03594721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*